U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H17N2O4S2.K
Molecular Weight 368.513
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALMECILLIN POTASSIUM

SMILES

[K+].[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CSCC=C)C([O-])=O

InChI

InChIKey=ONYTXCTVWDZLFD-GITWGATASA-M
InChI=1S/C13H18N2O4S2.K/c1-4-5-20-6-7(16)14-8-10(17)15-9(12(18)19)13(2,3)21-11(8)15;/h4,8-9,11H,1,5-6H2,2-3H3,(H,14,16)(H,18,19);/q;+1/p-1/t8-,9+,11-;/m1./s1

HIDE SMILES / InChI
Molecular Formula K
Molecular Weight 39.0983
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C13H17N2O4S2
Molecular Weight 329.415
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

ALMECILLIN (also known as penicillin O) is an antibiotic that can be safely substituted for penicillin G in instances of hypersensitivity reactions to the latter.

Approval Year

1950
102
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Not Provided
504
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
1000000 unit 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000000 unit, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000000 unit, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
unhealthy, 23 years
n = 1
Health Status: unhealthy
Condition: rheumatoid spondylitis
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
Other AEs: Nausea, Increased salivation...
Other AEs:
Nausea (mild)
Increased salivation
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
600000 unit single, intramuscular
Dose: 600000 unit
Route: intramuscular
Route: single
Dose: 600000 unit
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
unhealthy, 23 years
n = 1
Health Status: unhealthy
Condition: rheumatoid spondylitis
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
Disc. AE: Anaphylactic shock...
AEs leading to
discontinuation/dose reduction:
Anaphylactic shock (severe)
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
AEs

AEs

AESignificanceDosePopulation
Increased salivation
1000000 unit 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000000 unit, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000000 unit, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
unhealthy, 23 years
n = 1
Health Status: unhealthy
Condition: rheumatoid spondylitis
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
Nausea mild
1000000 unit 1 times / day multiple, intramuscular
Highest studied dose
Dose: 1000000 unit, 1 times / day
Route: intramuscular
Route: multiple
Dose: 1000000 unit, 1 times / day
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
unhealthy, 23 years
n = 1
Health Status: unhealthy
Condition: rheumatoid spondylitis
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
Anaphylactic shock severe
Disc. AE
600000 unit single, intramuscular
Dose: 600000 unit
Route: intramuscular
Route: single
Dose: 600000 unit
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
unhealthy, 23 years
n = 1
Health Status: unhealthy
Condition: rheumatoid spondylitis
Age Group: 23 years
Sex: M
Population Size: 1
Sources:
https://pubmed.ncbi.nlm.nih.gov/13182618
Sourcing

Sourcing

Vendor/AggregatorIDURL
ABI Chem
AC1L2G0T
Alfa Chemistry
87-09-2
https://www.alfa-chemistry.com/cas_87-09-2.htm
ChemMol
99171458
http://www.chemmol.com/chemmol/99171458.html
ChemTik
CTK3E8703
Compound Cloud
71365
NovoSeek
71365
ZINC
ZINC000004214768
http://zinc15.docking.org/substances/ZINC000004214768
eMolecules
260188440
PubMed

PubMed

TitleDatePubMed
Use of penicillin O in patients hypersensitive to pencilling G.
1950 Jul 1
Clinical and pharmacologic studies with allylmercaptomethyl penicillin (penicillin O).
1951 Aug
Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin G and its degradation products.
1960 Dec 1
Some immunochemical properties of penicillenic acid. An antigenic determinant derived from penicillin.
1960 Dec 1
Patents

Patents

JPH0349690A
3
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:53:15 GMT 2023
Edited
by admin
on Sat Dec 16 09:53:15 GMT 2023
Record UNII
DP2X0D6YBT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALMECILLIN POTASSIUM
Common Name English
POTASSIUM PENICILLIN O
Common Name English
PENICILLIN O POTASSIUM SALT [MI]
Common Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3,3-DIMETHYL-7-OXO-6-(((2-PROPENYLTHIO)ACETYL)AMINO)-, MONOPOTASSIUM SALT, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.))-
Systematic Name English
PENICILLIN O POTASSIUM
Common Name English
Code System Code Type Description
CAS
897-61-0
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY
MERCK INDEX
m8478
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY Merck Index
PUBCHEM
23675011
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY
ChEMBL
CHEMBL2105909
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY
FDA UNII
DP2X0D6YBT
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY
EPA CompTox
DTXSID70237861
Created by admin on Sat Dec 16 09:53:15 GMT 2023 , Edited by admin on Sat Dec 16 09:53:15 GMT 2023
PRIMARY
Related Record Type Details
Structure of ALMECILLIN
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of ALMECILLIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966